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Vitamin C (ascorbic acid), and transglutaminase have been shown to induce 
mechanical changes within collagen-based blood vessel constructs. Recent studies have 
found that the mechanical properties of tissue-engineered blood vessel constructs can be 
improved through chemical stimulation using these agents. In this study, we use vitamin 
C to induce extracellular matrix collagen synthesis, and transglutaminase to crosslink 
collagen. These chemical agents yield increased cell growth and enhance the mechanical 
strength and integrity of collagen based blood vessel constructs. However, the addition of 
each of these agents must be balanced, as high concentrations may be toxic to the cells. 
Finally, we also increase cell seeding density to modulate gel compaction and speed up 
construct development time. We aim to define the effects of vitamin C, transglutaminase, 
and initial cell seeding density through mechanical testing to confirm the findings. 
Preliminary results indicate that TG/AA have a significant impact on tensile strength of 
the constructs and that varying initial cell seeding density may have a positive trend. This 
research aims to provide the foundation necessary for a successful attack on the Holy 











 Atherosclerosis is an inflammatory disease that results in the narrowing of arteries 
and eventually impairs blood flow due to plaque buildup.1 The narrowing of coronary 
arteries leads to decreased blood flow to the heart, ultimately leading to cardiac ischemia. 
Treatment for advanced stages of this disease involves coronary artery bypass graft 
surgery (CABG), the most commonly performed cardiac surgical procedure in the 
world.2 Unfortunately, native blood vessels are not reliably available because they may 
be diseased or because such vessels were already used in previous surgery.  Today, 
CABG surgery cannot be performed in patients who cannot provide native blood vessels. 
As a result, the replacement or repair of diseased vessels with natural or synthetic 
vascular grafts has become a routine treatment.3 Efforts to create synthetic small diameter 
vascular grafts have been unsuccessful. Ultimately, an alternative to native blood vessels 
is needed, and thus, small-diameter blood vessel substitutes need to be further 
researched. 4 This project investigates whether certain biochemical stimulation and 
changes in initial cell composition can improve mechanical properties of tissue-






 Vascular tissue engineering is dedicated to the creation of functional blood 
vessels in vitro primarily for treating cardiovascular disease through vascular grafts or 
studying vascular biology by creating improved vascular models. However, there are still 
many challenges and questions that must be answered before an adequate blood vessel 
alternative is available. Developing blood vessels with adequate mechanical strengths and 
hemocomatibility are two of the challenges we face.5 The question that has to be 
answered for vascular tissue engineering to succeed is how to manipulate cell function in 
culture when the cells have been removed from their native environment. When placed in 
culture, vascular smooth muscle cells exhibit a synthetic phenotype with increased 
proliferation, increased matrix production, increased protease production, and altered cell 
contractility.3 The main goal in vascular tissue engineering is to manipulate cell function 
and improve the properties of engineered tissues in vitro while still maintaining function 
similar to that of native vessels. 
 Chemical stimulation has been found to improve the mechanical properties of 
tissue-engineered blood vessel (TEBV) constructs in many studies. Specifically, chemical 
stimulation has been shown to induce mechanical changes leading to stronger TEBV 
constructs. Vitamin C (Ascorbic Acid, AA) has been shown to induce extracellular 
matrix (ECM) collagen. The resulting cell matrix is sufficient in strength to withstand 
pressures greater than those experienced in vivo. Specifically, AA is said to stimulate 
collagen synthesis, which yields cell growth.3 However, the effects of AA on elasticity 
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are unknown. Some have reported that the AA-induced strength is accompanied by a 
significant increase in stiffness.   
 Transglutaminase (TG) has been established as a successful crosslinking agent of 
collagen to produce viable cell-seeded crosslinked gels with significantly enhanced 
mechanical strength.6 It is also responsible for tissue stabilization because they form high 
molecular weight complexes through this chemical crosslinking. This is important 
because the endothelial cells that line the inner surface are involved in the functionality of 
vessel walls, which include the maintenance homeostasis within the blood, transport 
regulation, and cell signaling. Thus, it is paramount to have a synthetic vessel that is 
compatible with the arterial wall.  
 A fundamental problem with the current development process of collagen-based 
blood vessel constructs is the amount of time required to fully develop these constructs. 
With the ultimate goal of rapid development of constructs, it is important to minimize 
development time. Currently, the standard cell seeding density is 1 x 106 cells/ml.4, 7-9 
Previous studies have shown that using a cell seeding density over 1 x 106 cells/ml may 
have detrimental effects on the cells, resulting in cell apoptosis. However, it may be 
possible to increase the rate of gel compaction without sacrificing cell viability by 
optimizing initial cell seeding concentrations. 
 Several groups have attempted to create small diameter blood vessels, but in all of 
these studies, there are still more questions that need to be answered. Many of these same 
groups determined that collagen has a significant positive impact on cell attachment and 
cell signaling, yet that it is intrinsically weak.3-7 Stegemann and Nerem found that 
collagen type 1 matrices caused a shift in the smooth muscle cell phenotype towards a 
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more synthetic state, characterized in part by a loss of important contractile proteins.5 
They also determined that collagen decreased cellular proliferation due to cell-cell 
contact inhibition as the gels compact. Accordingly, Stegemann and Nerem verified that 
biochemical stimulation such as TGF-ß affects gel compaction. As a result, other 
biochemical stimulation treatments such as ascorbic acid and retinoic acid can be used to 
see their effects.  
 In another study, Ogle et al. (2002) performed uniaxial mechanical tests on their 
constructs.4 Biaxial mechanical tests, however, may yield more accurate and meaningful 
results. Finally, Orban et al. (2004) found that enzymes such as TG could be used to 
crosslink cell-seeded collagen gels for improved mechanical strength; however, the 
addition of high concentrations of TG could be toxic to the cells.6 Finding an ideal 
concentration of TG can solve this problem of cytotoxicity, which would allow for stiffer 
constructs and more desirable mechanical properties. Thus, all of these studies paved the 
way for this research to find ways to improve the mechanical strength and integrity of 
blood vessel constructs.  
 The specific goal of this research, in addition to determining an optimal cell 
seeding concentration, is to treat blood vessel constructs with AA and TG and to test the 
mechanical strength and integrity of the constructs after the introduction of these agents. 
The purpose of this research is to provide the foundation necessary for a successful attack 





MATERIALS AND METHODS 
 
The first of the experiments was broken down into four components: (1) smooth 
muscle cells were cultured. (2) Collagen based blood vessel constructs were created with 
different concentrations of TG. Fixed cell concentrations were used in each construct. (3) 
The constructs were treated with ascorbic acid during incubation. (4) The constructs were 
subjected to mechanical testing on specific sections. The second experiment was 
similarly completed as the first, but with varying cell seeding concentrations. The data 
was then analyzed to verify the effects of each of the individual treatments. The research 
performed resulted in the determination of the preliminary effects of AA and TG on 
mechanical strength and integrity of blood vessel constructs as well as the determination 
of the effects of varying initial cell seeding densities.  
3.1 Culturing of Rat Aortic Smooth Muscle Cells (RASMCs) 
 Adult rat aortic smooth muscle cells were cultured to create blood vessel 
constructs.  The cultures were maintained in high-glucose Dulbecco’s modified eagle 
medium (DMEM) supplemented with L-glutamine (Sigma), penicillin-streptomycin 
(Hyclone), and 10% fetal bovine serum (FBS) (Cellgro). Cells were stored in liquid 
nitrogen if not used immediately. Cells were subsequently thawed and cultured according 
to methods described by Seliktar et al.4 They were grown below a passage of 15. Once 
the cells were ready, they were used in the fabrication of blood vessel constructs. 
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3.2 Fabrication of Blood Vessel Constructs 
3.2.1  Initial Preparation 
 First, the collagen solution was prepared by the addition of 0.02 N acetic acid to 
lyophilized collagen to gain a final concentration of 4mg/ml. Next, 5X Dulbecco's 
modified eagle medium (DMEM) was prepared using powdered DMEM. The last 
solution prepared was 0.1 M NaOH through dilution. Mandrels were formed using a 
3mm hollow glass rod. Two layers of rubber stoppers were placed on both ends of the 
mandrel and sized for fitting a glass test-tube. Finally, all instruments, test tubes, caps, 
and assembled mandrels were autoclaved. Once preparation was complete, the materials 
were used for creating the construct solution and used in construct assembly. 
3.2.2  Construct Solution 
 Initially, 5X DMEM, collagen solution and NaOH were placed on ice. Cells were 
then be trypsinized and counted. The cell count was inputted into a construct spreadsheet 
to calculate the amount of cell suspension, NaOH, 5X DMEM and collagen needed for 
making the constructs to achieve the final concentrations: 5 ml of final solution per test 
tube/construct, 1 million cells/ml, 2 mg/ml collagen, 1 ml 5X DMEM to 4 ml bovine 
collagen solution, 1 ml NaOH to 6 ml bovine collagen solution, and used the remainder 
of the determined volume for the culture medium. Next, the calculated volume of cell 
suspension was centrifuged and placed on ice. The construct solution was made by gently 
resuspending the cells in the calculated volume of culture medium to which 5X DMEM 
was added to collagen and was mixed followed by the addition of NaOH to collagen. The 
cell suspension to collagen solution was quickly added and gently mixed and left on ice, 
making sure the solution was thoroughly mixed avoiding bubbles. In experiments with 
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varying cell seeding concentrations, concentrations of 2.5 million [2.5X] cells/ml and 5 
million [5X] cells/ml were used. 
3.2.3  Construct Assembly 
 Test tubes were put into test tube holders and 5 ml of construct solution was added 
into each test tube. Using mandrel grabbers, a mandrel was inserted into each test tube. 
The test tubes were then capped and placed in an incubator for 30-45 minutes to allow for 
gelation and polymerization. Once the constructs were determined to have gelled, the 
caps were removed and a glass pipette was used to aspirate a very small amount of fluid 
and gel from inside the glass rods to prevent hydraulic lock. Mandrel grabbers were then 
used again to remove the constructs from the test tubes, which were placed in culture 
dishes in 120 ml of medium. The constructs were released from the stoppers with scissors 
and mandrel grabbers for support, and any excess material was discarded.  Finally, the 




Figure 1: Summary of Construct Assembly. The construct solution is first prepared 
and added to a cell solution. Once mixed, the resulting solution is transferred into 
individual test tubes and mandrels are placed into each test tube. The test tubes were then 
placed in an incubator for 30-45 minutes or until polymerization. Following 
polymerization, the constructs were removed from the test tubes and placed in culture 
dishes with media and incubated for the duration of the experiment. Once compacted, the 




3.3 Optimization of Transglutaminase Crosslinking 
 The manufactured constructs were treated with 2 µg/ml (1:1000 C:E), 0.4 µg/ml 
(1,:5,000 C:E) and 0.2 µg/ml (1:10,000 C:E) of TG to find the optimal concentration for 
successful crosslinking during the construct solution fabrication. A 2,4,6-
trinitrobenzenesulfonic acid (TNBS) assay was used to analyze end groups to find the 
extent of reaction through transamidation. The number of free amine groups was 
quantified by TNBS absorption. After gelation, a solution containing 4% NaHCO3 and 
0.5% TNBS was added to each well, and the plates were incubated in the dark at 37°C for 
2 hours. 6 M HCl was added and the temperature was maintained at 37°C until 
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solubilization of the gel. The resulting solutions were aliquotted into a 96-well plate. 
Finally, the absorbance was measured at 345nm using a microplate spectrophotometer.6 
3.4 Treatment with Ascorbic Acid 
 To demonstrate the effects of AA on the biomechanical properties of the tissue-
engineered blood vessels, 0.3 mM AA was added to the media. Media was changed 
approximately 3 times per week. The effects were measured at 14 days and compared to 
the controls.5  
3.5 Mechanical Testing 
3.5.1  Ring Tests 
 Mechanical testing was performed 14 days after construct formulation. The 
tensile properties of the constructs were measured using 5 mm wide rings cut from the 
tubular constructs. Carbon markers were placed on the rings to allow for the 
measurement of the true local strain of the material during testing upon particle tracking 
of images taken during testing. The rings were placed between two hooks on an Instron 
mechanical testing device in phosphate buffered solution (PBS). After being 
preconditioned by 5 stretches to 1 mm greater the unstretched length, the construct rings 
were stretched to failure at constant displacement rates of 0.1 mm/s, 1 mm/s, and 10 
mm/s as the load/extension data was recorded. A force transducer and video imaging 
system was used to ensure the accuracy of the measurements and for further analysis.4 
These tests were performed on constructs treated with TG/AA and controls. See Figure 2 





Figure 2: Ring Test Setup. 5 mm wide rings were cut from each tubular construct. The 
rings were placed between two hooks on an Instron mechanical testing device. The fixed 




3.5.2  Burst Pressure Tests 
 Pressure-diameter tests were performed 14 days after construct assembly. Each 
end of the construct was slid onto a metal cannula and secured using suture thread and 
placement grooves (See Figure 3). A mechanical testing apparatus composed of flow 
control, pressure control, axial motion control, and geometry-monitoring subsystems. A 
mechanical fluid circuit loop was created using PBS: (1) a reservoir of PBS was created 
using a stopper-sealed Erlenmeyer flask with leads for tube connections, (2) a pressure 
transducer, (3) a PBS bath for the construct, and (4) a second pressure transducer. The 
fluid pressure was controlled by blocking flow in the tube leading to the flask and then 
modifying the pressure in the air space above the fluid in the flask. The pressure inside 
the construct was calculated by taking the average of the two pressures at the pressure 
transducers. Increasing the internal pressure at a constant rate and recording the 
maximum pressure inside the construct before rupture measured burst pressure. The 
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diameter of the construct was constantly measured using webcam-based geometry-
monitoring subsystem. All burst pressure and diameter data was collected using a custom 
coded National Instruments LabVIEW virtual instrument. These tests were completed on 





Figure 3: Burst Pressure Test Setup. Each end of the construct was placed on a metal 




3.6 Statistical Analysis 
 Ring test data were analyzed by calculating the mean ultimate tensile load for 
each group (Control, TG/AA) of constructs at different extension rates (0.1 mm/s, 1 
mm/s, 10 mm/s) after 14 days of treatment.  These values were compared within each 
extension rate using the two-sample t-test function, ttest2, in Mathworks Matlab r2010a. 
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The hypothesis for this test is that the mean ultimate tensile loads are not equal. The null 
hypothesis is that the means are equal. Burst pressure test data were analyzed by taking 
the mean pressure peak attained until specimen failure and comparing each test group 
(Control – [1X], [2.5X], [5X]) to another using a two-sample t-test function in 
Mathworks Matlab. The hypothesis for this test is that the mean bust pressures are not 
equal. The null hypothesis is that the means are equal. No statistical analysis was 






4.1 Transglutaminase Crosslinking 
 Amine group quantification was used to attempt to measure the extent of 
crosslinking. As the ratio of collagen:enzyme was varied between 10,000:1, 5000:1, 
1000:1 (w/w), including a non-crosslinked control, the TNBS absorbance should have 
decreased thereby signifying a decrease in amine groups present with increasing enzyme 
concentration. Analyses should have indicated a significant difference in number of 
amine groups present between the non-crosslinked and all of the crosslinked disks. 
However, the assay failed to yield any results. No tubular constructs were made with 
different TG concentrations, so burst pressure tests were not performed. Representative 











Figure 4: Representative Amine Group Content of Crosslinked Collagen Gels. 
Average TNBS absorption (345 nm) is plotted against TG concentration. The value at 0 
collagen:enzyme represents the non-crosslinked control. This is to verify that collagen 





Figure 5: Representative Mean Burst Pressure of Constructs. Burst pressure was 
measured by peak pressure (mm Hg) attained prior to specimen failure. Control versus 
5,000:1 Collagen:TG shown. Crosslinking collagen improves burst pressure resistance, 
allowing the constructs to still function at high pressures. 
Absorbance	  vs.	  Crosslinking	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4.2 Transglutaminase/Ascorbic Acid Treatment 
 Ring tests were performed on TG/AA treated and control tubular constructs to 
compare ultimate tensile load at uniaxial extension of 0.1 mm/s, 1 mm/s and 10 mm/s. A 
two-sample t-test with a = 0.05 was used to confirm that the addition of TG/AA had a 
significant effect on ultimate tensile load. TG/AA treated TEBVs had significantly more 
strength at 0.1 mm/s and 10 mm/s uniaxial extension than the controls. Uniaxial loading 
at 1 mm/s did not yield any statistically significant results due to high standard deviation. 
10 mm/s uniaxial loading resulted in higher ultimate tensile load recordings for TG/AA 
treated TEBVs than any other group at any extension rate. The p-values at 0.1 mm/s, 1 
mm/s, and 10 mm/s uniaxial extension were 0.0071, 0.0743, and 0.0408. Ultimate tensile 
load of each of the groups is shown in Figure 6. A representative load vs. extension plot 




Figure 6: Ultimate Tensile Load of Tubular Construct Controls and TG/AA Treated 
Constructs during Uniaxial Testing. TG/AA treated constructs tested at 0.1 mm/s and 
10 mm/s were significantly stronger than controls. 5,000:1 Collagen:TG, 0.3 mM AA 





Figure 7: Representative Load vs. Extension Plot for TEBV. Uniaxial extension at 10 
mm/s was performed on ring sample from control group following 14 days of incubation. 
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4.3 Initial Cell Seeding Density 
 A two-sample t-test with a = 0.05 was used to determine that the burst pressures 
recorded for each group (Control – [1X], [2.5X], [5X]) were not significantly different. 
The burst pressure tests were performed on tubular constructs with varying initial seeding 
concentrations. Although the results were not statistically significant, there was an 
increasing trend in burst pressure, with the [5X] having the highest pressure as seen in 
Figure 8. Comparing the [2.5X] to the control, [2.5X] to the [5X], and [5X] to the control 





Figure 8: Mean Burst Pressure of Tubular Constructs with Varying Initial Cell 
Seeding Concentrations. Burst pressure was defined as the peak pressure (mm Hg) 
attained prior to specimen failure. [2.5X] and [5X] constructs did have higher burst 
pressures, but the increase was not significant. Error bars, means ± SD; [1X]: n=2, 





 The importance of finding a means to improve the mechanical strength and 
integrity of collagen-based tissue engineered blood vessels is widely recognized and is 
one of the most pressing issues in the vascular tissue engineering community. Collagen-
based blood vessel constructs have been intrinsically weak since conception. This 
research was conducted to determine whether crosslinking collagen, adding exogenous 
biochemical stimuli, and varying initial cell seeding densities would positively influence 
the mechanical properties of collagen based TEBVs. It was hypothesized that these 
stimuli and changes in initial properties would affect the mechanical properties of 
TEBVs. 
 It was determined that the addition of TG/AA to the TEBVs exhibited increased 
tensile strength from the data obtained from ring tests. Although the 1 mm/s extension 
did not yield significant improvement, this issue can most likely be handled through 
testing a larger sample size because the standard deviations for this particular set was 
almost three times more than the data obtained from 0.1 mm/s extension. The results 
obtained, however, support the hypothesis that the addition of TG/AA improves the 
mechanical properties of TEBVs. 
 Another facet of the development process of TEBVs that was examined was the 
initial cell seeding density when manufacturing the cells. Results from burst pressure 
tests showed that the increased concentration of cells increased the vessel’s ability to 
withstand pressure. However, the increase was not statistically significant. This is mainly 
due to the fact that very few samples yielded results. The original sample size per group 
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was n = 3, but some vessels were found to have defects such as shorter lengths and tears. 
Leaks also occurred to ruin some vessels. Thus, the sample size fell to n = 2 and even n = 
1 for the [5X] samples.  Performing this portion with a greater sample size again may 
yield statistical significance. 
 The third specific aim of this study was to determine the optimal TG 
concentration for collagen crosslinking. The protocol for making disks to verify collagen 
crosslinking was performed correctly, however, when completing the experiment with the 
TNBS assay, the absorbance plate reader did not give sensible data because 0.0000 was 
outputted for all the wells in the plate. It is unknown why this happened; however, it may 
be due to the concentrations being inaccurate. The concentrations, nonetheless, were 
verified to be correct.  
 Crosslinking collagen in the constructs through the addition of TG has previously 
been proven to facilitate structurally robust constructs by increasing their mechanical 
strength and integrity.6 However, that previous research was done with bone muscle cells, 
and not aortic smooth muscle cells. Ascorbic acid has been widely recognized in 
increasing the collagen content within the extracellular matrix of cells.3 Thus, it was 
externally added to the media after the constructs were fabricated. Mechanical testing 
was performed in the form of ring tests and burst pressure tests. The results obtained 
conformed to expectations, but their impact was less noticeable than anticipated. A 
greater sample size would in general solve the issue because of previous results that 
lacked statistical significance.   
 Further limitations of this experiment were present, which compromised some 
results that were as a result unusable. There are many possible situations than could have 
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adversely affected the results of this research. Some of these may include equipment 
failure, compromised sterility of the constructs, inadequate mixing of construct solutions, 
lack of CO2 due to tank depletion, incomplete data acquisition, or improper plate readings 
for assays.   
 Future studies should include variations of TG concentrations along with AA 
proceeded with ring tests. Vitamin A (Retinoic Acid, RA) has been demonstrated to 
induce elastin synthesis in isolated vascular smooth muscle cells (VSMCs), which is 
important for the mechanical properties of the constructs.3 Thus, this should be looked 
into for further manipulating the mechanical properties of TEBVs. Beyond looking at just 
tensile strength, modulus and other material properties should be analyzed as well with 
these given treatments. TGF-ß and insulin have also been shown to improve the 
mechanical properties of TEBVs.11 Biaxial testing should also be performed on future 





 The hypothesis that TG/AA have an impact on the mechanical properties of 
TEBVs was supported by the findings of this research. Biochemical stimulation has been 
identified as a means for improving the mechanical properties, such as tensile stress, load, 
yield, and modulus. Furthermore, it was determined that increasing initial cell seeding 
density may have an impact on the development time of these constructs and without 
degrading any mechanical properties. Biochemical stimulation is a critical technique that 
must be further explored to improve the strength and integrity of these vessels. 
Eventually, the mechanical integrity of the constructs will be improved upon using these 
techniques and may one day lead to synthetic small diameter blood vessels that can be 
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